The latest medical technology coverage from Hawaii Medical Journal.
A recent Nature Medicine study demonstrates that somatic loss of the Y chromosome significantly increases type 2 diabetes risk in East Asian men, particularly those with low polygenic risk scores, with direct evidence of Y chromosome loss in pancreatic β-cells.
Analysis of recent federal funding restrictions reveals substantial decline in human fetal tissue research support, with implications for developmental biology studies, vaccine production, and disease modeling capabilities.
An LLM-assisted systematic review of 4,609 clinical studies published between 2022-2025 demonstrates that only 22.7% utilized real-world patient data, with merely 19 prospective randomized trials conducted. The analysis reveals substantial evidence gaps despite rapid proliferation of medical AI research at 3.2 publications per day.
A phase 1 clinical trial of liver-targeted PCSK9 base editing demonstrates preliminary efficacy for familial hypercholesterolemia treatment, though significant optimization challenges remain for clinical translation. The study represents an important milestone in applying CRISPR-based therapeutics to cardiovascular disease management.